Samuel Blay Nguah

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Arjen M. Dondorp, Ilse C. E. Hendriksen, Ermelinda Gomes et al. · The Lancet · 2010 · 1K citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

Genome-wide association study indicates two novel resistance loci for severe malaria

Christian Timmann, Thorsten Thye, Maren Vens et al. · Nature · 2012 · 280 citations

Life Sciences, Genetics, Molecular Genetics +14

Predicting the Clinical Outcome of Severe Falciparum Malaria in African Children: Findings From a Large Randomized Trial

Lorenz von Seidlein, Rasaq Olaosebikan, Ilse C. E. Hendriksen et al. · Clinical Infectious Diseases · 2012 · 191 citations · Full text

Public Health, Infectious Diseases, Pediatrics +16

Hemoglobin estimation by the HemoCue® portable hemoglobin photometer in a resource poor setting

Bernard Nkrumah, Samuel Blay Nguah, Nimako Sarpong et al. · BMC Clinical Pathology · 2011 · 178 citations · Full text

Medicine, Hematology, Analytical Chemistry +12

Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data

Sarah Tougher, Yazoume Yé, John Amuasi et al. · The Lancet · 2012 · 175 citations

Public Affairs, Health Sciences, Pharmaceutical Policy +15